LifeMD (LFMD) Research & Development (2019 - 2025)
LifeMD (LFMD) reported Research & Development of -$920045.0 for Q4 2025, down 276.07% on a YoY basis from $522557.5 in Q4 2024, and down 132.32% quarter-over-quarter from $2.8 million in Q3 2025.
LifeMD (LFMD) Research & Development (2019 - 2025) Analysis & Trends
LifeMD has reported Research & Development for 7 years, with the latest figure at -$920045.0 in Q4 2025.
- For the quarter ending Q4 2025, Research & Development fell 276.07% year-over-year to -$920045.0; the trailing twelve-month figure through Dec 2025 stood at $7.3 million (up 7.13% YoY), and the FY2025 full-year result was $7.3 million, up 7.13% from the prior year.
- Research & Development for Q4 2025 stood at -$920045.0, down from $2.8 million in the prior quarter.
- The five-year high for Research & Development was $2.8 million in Q3 2025, with the low at -$920045.0 in Q4 2025.
- Historically, Research & Development has averaged $1.2 million across 5 years, with a median of $1.1 million in 2022.
- Annual changes were most pronounced in 2022 — Research & Development surged 541.23% — and 2025, when it sank 276.07%.
- LifeMD's Research & Development stood at $216979.0 in 2021, then surged by 369.71% to $1.0 million in 2022, then soared by 96.04% to $2.0 million in 2023, then sank by 112.24% to -$244650.0 in 2024, then slumped by 276.07% to -$920045.0 in 2025.
- The last three Research & Development figures came in at -$920045.0 (Q4 2025), $2.8 million (Q3 2025), and $2.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 208.32 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 67.77 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 30.34 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 56.85 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 39.11 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 18.37 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 21.52 Mn |
| 10 | LifeMD | 226.03 Mn | 226.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -920,045.00 |
| Sep 30, 2025 | 2.85 Mn |
| Jun 30, 2025 | 2.74 Mn |
| Mar 31, 2025 | 2.68 Mn |
| Dec 31, 2024 | -244,650.00 |
| Sep 30, 2024 | 2.61 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 2.09 Mn |
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | 1.50 Mn |
| Jun 30, 2023 | 1.38 Mn |
| Mar 31, 2023 | 1.18 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 821,636.00 |
| Jun 30, 2022 | 701,070.00 |
| Mar 31, 2022 | 428,333.00 |
| Dec 31, 2021 | 216,979.00 |
| Sep 30, 2021 | 128,134.00 |
| Jun 30, 2021 | 122,603.00 |
| Mar 31, 2021 | 311,056.00 |